AU2002220584A1 - Use of lipopeptides or lipoproteins for treating lung infections and lung tumours - Google Patents

Use of lipopeptides or lipoproteins for treating lung infections and lung tumours

Info

Publication number
AU2002220584A1
AU2002220584A1 AU2002220584A AU2002220584A AU2002220584A1 AU 2002220584 A1 AU2002220584 A1 AU 2002220584A1 AU 2002220584 A AU2002220584 A AU 2002220584A AU 2002220584 A AU2002220584 A AU 2002220584A AU 2002220584 A1 AU2002220584 A1 AU 2002220584A1
Authority
AU
Australia
Prior art keywords
lung
lipopeptides
lipoproteins
tumours
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002220584A
Other versions
AU2002220584B2 (en
AU2002220584B8 (en
Inventor
Anke Luehrmann
Peter Muehlradt
Reinhard Pabst
Thomas Tschernig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Original Assignee
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10048840A external-priority patent/DE10048840A1/en
Application filed by Helmholtz Zentrum fuer Infektionsforschung HZI GmbH filed Critical Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Application granted granted Critical
Publication of AU2002220584B8 publication Critical patent/AU2002220584B8/en
Publication of AU2002220584A1 publication Critical patent/AU2002220584A1/en
Assigned to HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH reassignment HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH Request for Assignment Assignors: GESELLSCHAFT FUR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF)
Publication of AU2002220584B2 publication Critical patent/AU2002220584B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002220584A 2000-10-02 2001-10-02 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours Ceased AU2002220584B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10048840.4 2000-10-02
DE10048840A DE10048840A1 (en) 2000-10-02 2000-10-02 Use of lipopeptides or lipoproteins to treat lung infections and tumors
PCT/EP2001/011414 WO2002028887A2 (en) 2000-10-02 2001-10-02 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours

Publications (3)

Publication Number Publication Date
AU2002220584B8 AU2002220584B8 (en) 2002-04-15
AU2002220584A1 true AU2002220584A1 (en) 2002-06-27
AU2002220584B2 AU2002220584B2 (en) 2007-08-09

Family

ID=7658473

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002220584A Ceased AU2002220584B2 (en) 2000-10-02 2001-10-02 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
AU2058402A Pending AU2058402A (en) 2000-10-02 2001-10-02 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2058402A Pending AU2058402A (en) 2000-10-02 2001-10-02 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours

Country Status (10)

Country Link
US (2) US20040249133A1 (en)
EP (1) EP1322321B1 (en)
JP (1) JP4541642B2 (en)
AT (1) ATE399018T1 (en)
AU (2) AU2002220584B2 (en)
CA (1) CA2424285A1 (en)
DE (2) DE10048840A1 (en)
DK (1) DK1322321T3 (en)
ES (1) ES2309105T3 (en)
WO (1) WO2002028887A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652586A1 (en) * 1996-12-17 1998-06-18 Biotechnolog Forschung Gmbh Dhc peptide and agent
EA014644B1 (en) 2005-06-13 2010-12-30 Кливлэнд Биолабс Инк. Methods of protection against apoptosis using lipopeptides
DE102009034779A1 (en) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetic analogues of bacterial lipopeptides and their application for the therapy and prophylaxis of allergic diseases
EP2305283A1 (en) 2009-09-24 2011-04-06 Helmholtz-Zentrum für Infektionsforschung GmbH Pharmaceutical compositions for treating dysregulated inflammatory diseases
DE102011018499A1 (en) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topical nanoparticle vaccine for the immune stimulation of dendritic cells in the skin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860893D1 (en) * 1977-06-20 1981-11-05 Ciba Geigy Ag Lipopeptides, process for their preparation and pharmaceutical compositions containing them
JPH0499796A (en) * 1990-08-13 1992-03-31 Kazuo Achinami New lipopeptide and antitumor agent
DE19652586A1 (en) * 1996-12-17 1998-06-18 Biotechnolog Forschung Gmbh Dhc peptide and agent
AU756433B2 (en) * 1997-07-12 2003-01-16 Societe Des Produits Nestle S.A. Coffee storage proteins
DE19822820A1 (en) * 1998-05-20 1999-11-25 Biotechnolog Forschung Gmbh Wound healing composition comprising lipopeptide or lipoprotein that stimulates leukocyte infiltration

Similar Documents

Publication Publication Date Title
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
CY2011012I2 (en) INHALED AZTREONAME FOR THE TREATMENT AND PREVENTION OF BACTERIAL PULMONARY INFECTIONS
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2001294834A1 (en) Recombinant bcg vaccines for the prevention and treatment of cancer
AU2002335085A1 (en) Angiopoietins and methods of use thereof
IL162689A0 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2002220584A1 (en) Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
EE200300057A (en) Ingredients for the prevention and treatment of cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001268236A1 (en) Use of aicar and related compounds
AU7402201A (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i